Filing Details

Accession Number:
0001808805-21-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-01 21:41:03
Reporting Period:
2021-11-30
Accepted Time:
2021-12-01 21:41:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808805 Nautilus Biotechnology Inc. NAUT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1543792 L. Matthew Posard C/O Nautilus Biotechnology, Inc.
2701 Eastlake Avenue East
Seattle WA 98102
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-30 20,000 $4.57 20,000 No 4 P Direct
Common Stock Acquisiton 2021-12-01 10,000 $4.50 30,000 No 4 P Direct
Common Stock Acquisiton 2021-12-01 10,000 $4.46 40,000 No 4 P Direct
Common Stock Acquisiton 2021-12-01 10,000 $4.45 50,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 100,000 Indirect See Footnote
Footnotes
  1. Shares held by the Matthew and Elizabeth Posard Trust. The reporting person is the Trustee of the Matthew and Elizabeth Posard Trust.